Uzin Utz SE (ETR:UZU)
Germany
· Delayed Price · Currency is EUR 76.50
-1.00 (-1.29%)
Mar 9, 2026, 5:35 PM CET
Uzin Utz SE Revenue
Uzin Utz SE had revenue of 251.75M EUR in the half year ending June 30, 2025, with 2.90% growth. This brings the company's revenue in the last twelve months to 486.35M, up 1.78% year-over-year. In the year 2024, Uzin Utz SE had annual revenue of 476.88M, down -0.70%.
Revenue (ttm)
486.35M
Revenue Growth
+1.78%
P/S Ratio
0.80
Revenue / Employee
317.05K
Employees
1,534
Market Cap
390.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 476.88M | -3.35M | -0.70% |
| Dec 31, 2023 | 480.23M | -7.72M | -1.58% |
| Dec 31, 2022 | 487.95M | 47.40M | 10.76% |
| Dec 31, 2021 | 440.55M | 56.35M | 14.67% |
| Dec 31, 2020 | 384.20M | 10.94M | 2.93% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| H&R GmbH & Co. KGaA | 1.30B |
| LANXESS Aktiengesellschaft | 5.89B |
| Masterflex SE | 101.09M |
| AlzChem Group AG | 575.05M |
| Nabaltec AG | 202.27M |
| Verbio SE | 1.73B |
| H2APEX Group SCA | 11.06M |
| BRAIN Biotech AG | 49.01M |